MassGeneral Institute for Neurodegenerative Disease

Translating today's discoveries into tomorrow's cures

Facebook icon Twitter Icon

News page banner

Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis

9/6/2018 - Study conducted by Merit Cudkowicz, MD, Eric C. Klawiter, MD and the NeuroNEXT team shows promise for treating progressive multiple sclerosis. Read the full article here